New rapid test could speed up sepsis diagnosis in ER
NCT ID NCT01904188
First seen Jun 19, 2026 · Last updated Jun 23, 2026 · Updated 1 time
Summary
This study is testing a new rapid diagnostic device called In-Dx to quickly identify infections and antibiotic resistance in emergency patients with suspected sepsis. Researchers will compare the device's results to standard lab cultures using stored samples from 2,500 patients. The goal is to see if the device can provide accurate results faster, but it will not affect current patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
McLaren Greater Lansing
RECRUITINGLansing, Michigan, 48910, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Michigan Health/Sparrow (name change only)
RECRUITINGLansing, Michigan, 48909, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
In-Dx rapid diagnostic device
What this could lead to
If successful, this could lead to faster, more accurate identification of infections and antibiotic resistance, potentially improving sepsis treatment.
What could go wrong
This is an early-stage diagnostic study that does not change patient care yet. The device may not be accurate enough or may not work in real-world settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.